Plancorp, LLC Seagen Inc. Transaction History

Plancorp, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$127.59 - $203.08 $5,103 - $8,123	40 Added 0.77%	5,265 $1.07 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $5,985 - $7,097	-51 Reduced 0.97%	5,225 $671,000
Q2 2022 Aug 04, 2022	BUY	$108.81 - $179.33 $4,787 - $7,890	44 Added 0.84%	5,276 $934,000
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $358 - $473	3 Added 0.06%	5,232 $754,000
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $855 - $1,145	-6 Reduced 0.11%	5,229 $808,000

Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $1,709 - $2,037	12 Added 0.23%	5,235 $889,000
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $945 - $1,127	-7 Reduced 0.13%	5,223 $825,000
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $3,025 - $4,197	-22 Reduced 0.42%	5,230 $726,000
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $864,636 - $1.11 Million	5,252 New	5,252 $920,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

Stay updated on Plancorp, LLC with notifications on news.